Cellular and Molecular Mechanisms Underlying Arterial Baroreceptor Remodeling in Cardiovascular Diseases and Diabetes

Huiyin Tu, Dongze Zhang, Yulong Li

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Clinical trials and animal experimental studies have demonstrated an association of arterial baroreflex impairment with the prognosis and mortality of cardiovascular diseases and diabetes. As a primary part of the arterial baroreflex arc, the pressure sensitivity of arterial baroreceptors is blunted and involved in arterial baroreflex dysfunction in cardiovascular diseases and diabetes. Changes in the arterial vascular walls, mechanosensitive ion channels, and voltage-gated ion channels contribute to the attenuation of arterial baroreceptor sensitivity. Some endogenous substances (such as angiotensin II and superoxide anion) can modulate these morphological and functional alterations through intracellular signaling pathways in impaired arterial baroreceptors. Arterial baroreceptors can be considered as a potential therapeutic target to improve the prognosis of patients with cardiovascular diseases and diabetes.

Original languageEnglish (US)
Pages (from-to)98-112
Number of pages15
JournalNeuroscience Bulletin
Volume35
Issue number1
DOIs
StatePublished - Feb 1 2019

Fingerprint

Pressoreceptors
Baroreflex
Cardiovascular Diseases
Ion Channels
Superoxides
Angiotensin II
Blood Vessels
Arterial Pressure
Clinical Trials
Mortality
Therapeutics

Keywords

  • Angiotensin II
  • Baroreceptor
  • Baroreflex
  • Cardiovascular disease
  • Diabetes
  • Mechanosensitive ion channels
  • Nuclear factor-kappa B
  • Superoxide
  • Vascular wall
  • Voltage-gated ion channels

ASJC Scopus subject areas

  • Neuroscience(all)
  • Physiology

Cite this

Cellular and Molecular Mechanisms Underlying Arterial Baroreceptor Remodeling in Cardiovascular Diseases and Diabetes. / Tu, Huiyin; Zhang, Dongze; Li, Yulong.

In: Neuroscience Bulletin, Vol. 35, No. 1, 01.02.2019, p. 98-112.

Research output: Contribution to journalReview article

@article{256580a2e4c2443b9ea731d964d720a8,
title = "Cellular and Molecular Mechanisms Underlying Arterial Baroreceptor Remodeling in Cardiovascular Diseases and Diabetes",
abstract = "Clinical trials and animal experimental studies have demonstrated an association of arterial baroreflex impairment with the prognosis and mortality of cardiovascular diseases and diabetes. As a primary part of the arterial baroreflex arc, the pressure sensitivity of arterial baroreceptors is blunted and involved in arterial baroreflex dysfunction in cardiovascular diseases and diabetes. Changes in the arterial vascular walls, mechanosensitive ion channels, and voltage-gated ion channels contribute to the attenuation of arterial baroreceptor sensitivity. Some endogenous substances (such as angiotensin II and superoxide anion) can modulate these morphological and functional alterations through intracellular signaling pathways in impaired arterial baroreceptors. Arterial baroreceptors can be considered as a potential therapeutic target to improve the prognosis of patients with cardiovascular diseases and diabetes.",
keywords = "Angiotensin II, Baroreceptor, Baroreflex, Cardiovascular disease, Diabetes, Mechanosensitive ion channels, Nuclear factor-kappa B, Superoxide, Vascular wall, Voltage-gated ion channels",
author = "Huiyin Tu and Dongze Zhang and Yulong Li",
year = "2019",
month = "2",
day = "1",
doi = "10.1007/s12264-018-0274-y",
language = "English (US)",
volume = "35",
pages = "98--112",
journal = "Neuroscience Bulletin",
issn = "1673-7067",
publisher = "Science Press",
number = "1",

}

TY - JOUR

T1 - Cellular and Molecular Mechanisms Underlying Arterial Baroreceptor Remodeling in Cardiovascular Diseases and Diabetes

AU - Tu, Huiyin

AU - Zhang, Dongze

AU - Li, Yulong

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Clinical trials and animal experimental studies have demonstrated an association of arterial baroreflex impairment with the prognosis and mortality of cardiovascular diseases and diabetes. As a primary part of the arterial baroreflex arc, the pressure sensitivity of arterial baroreceptors is blunted and involved in arterial baroreflex dysfunction in cardiovascular diseases and diabetes. Changes in the arterial vascular walls, mechanosensitive ion channels, and voltage-gated ion channels contribute to the attenuation of arterial baroreceptor sensitivity. Some endogenous substances (such as angiotensin II and superoxide anion) can modulate these morphological and functional alterations through intracellular signaling pathways in impaired arterial baroreceptors. Arterial baroreceptors can be considered as a potential therapeutic target to improve the prognosis of patients with cardiovascular diseases and diabetes.

AB - Clinical trials and animal experimental studies have demonstrated an association of arterial baroreflex impairment with the prognosis and mortality of cardiovascular diseases and diabetes. As a primary part of the arterial baroreflex arc, the pressure sensitivity of arterial baroreceptors is blunted and involved in arterial baroreflex dysfunction in cardiovascular diseases and diabetes. Changes in the arterial vascular walls, mechanosensitive ion channels, and voltage-gated ion channels contribute to the attenuation of arterial baroreceptor sensitivity. Some endogenous substances (such as angiotensin II and superoxide anion) can modulate these morphological and functional alterations through intracellular signaling pathways in impaired arterial baroreceptors. Arterial baroreceptors can be considered as a potential therapeutic target to improve the prognosis of patients with cardiovascular diseases and diabetes.

KW - Angiotensin II

KW - Baroreceptor

KW - Baroreflex

KW - Cardiovascular disease

KW - Diabetes

KW - Mechanosensitive ion channels

KW - Nuclear factor-kappa B

KW - Superoxide

KW - Vascular wall

KW - Voltage-gated ion channels

UR - http://www.scopus.com/inward/record.url?scp=85052651991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052651991&partnerID=8YFLogxK

U2 - 10.1007/s12264-018-0274-y

DO - 10.1007/s12264-018-0274-y

M3 - Review article

C2 - 30146675

AN - SCOPUS:85052651991

VL - 35

SP - 98

EP - 112

JO - Neuroscience Bulletin

JF - Neuroscience Bulletin

SN - 1673-7067

IS - 1

ER -